News

A new probiotic has just been released, based on the discovery that bacteria present on healthy skin called Roseomonas mucosa can safely relieve eczema symptoms.

Empa researchers are developing polymer fibers that can deliver active ingredients precisely over the long term. These "liquid core fibers" contain drugs inside and can be processed into medical textiles.

The use of the active ingredient 3,4-methylenedioxy-N-methylamphetamine (MDMA), commonly known as "ecstasy", to support psychotherapy for mental illnesses such as post-traumatic stress disorder is being discussed worldwide.

Researchers from the Department of Bioengineering (BE), Indian Institute of Science (IISc), have designed a novel 3D hydrogel culture system that mimics the mammalian lung environment.

A new clinical trial suggests that an antidiabetic drug, tirzepatide, could effectively treat obstructive sleep apnea (OSA). These data could pave the way to improved quality of life for people affected by the sleep-related disorder.

Research has found that a new tablet form of ketamine has shown promise in treating severe depression, offering a potential alternative to existing clinic-based treatments that can be expensive and lacking in convenience for some patients.

The LENS trial has demonstrated that fenofibrate, a drug usually used to lower cholesterol, reduces the risk of progression of diabetic retinopathy by 27%. The results were announced today at the American Diabetes Association Scientific Sessions.

In a new study, researchers have studied how the brain memorizes and updates the goals to be achieved. The study reveals differences in how we process immediate and distant goals at both behavioral and cerebral levels.

A recent study investigated whether a transglutaminase 2 inhibitor has potential as a drug to treat celiac disease. Previous tissue studies have shown that the ZED1227 transglutaminase 2 inhibitor prevents gluten-induced intestinal damage.

Researchers have found promising evidence that brigatinib, a small molecule treatment approved for the treatment of lung cancer, helps to shrink the tumors of patients with NF2-related schwannomatosis.